Last reviewed · How we verify
platelet rich fibrin
Platelet rich fibrin, marketed by Abeer Hassan Sharafuddin, is a therapeutic product currently available in the market. The key composition patent is set to expire in 2028, providing a period of exclusivity that supports market stability. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | platelet rich fibrin |
|---|---|
| Also known as | platelet concentrate, PRF, Natural growth factor |
| Sponsor | Abeer hassan sharafuddin |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Effects of I-PRF and C-PRF on Gingival Phenotype (NA)
- Clinical Comparison of Alb-PRF vs PRF on Postoperative Morbidity Following FGG Harvesting (NA)
- Hyaluronic Acid and Albumin-PRF in Non-Surgical Periodontal Therapy (NA)
- Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions (PHASE2, PHASE3)
- Platelet Rich Plasma Injections In Young And Old Human Subjects (PHASE2)
- Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis (NA)
- L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation (NA)
- Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- platelet rich fibrin CI brief — competitive landscape report
- platelet rich fibrin updates RSS · CI watch RSS
- Abeer hassan sharafuddin portfolio CI